A new clinical trial shows adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease.
from WebMD Health https://www.webmd.com/breast-cancer/news/20230606/targeted-drug-may-lower-odds-for-breast-cancers-return-in-some-patients?src=RSS_PUBLIC
0 Comments:
Post a Comment